Literature DB >> 35845337

The Forgotten Cost of Nephrotic Syndrome to Patients and Caregivers in the United States.

Arun Rajasekaran1, Dana V Rizk1.   

Abstract

Entities:  

Keywords:  United States; caregivers; direct cost; glomerular and tubulointerstitial diseases; glomerulonephritis; health economics; indirect cost; nephrotic syndrome

Mesh：

Year:  2022        PMID： 35845337      PMCID： PMC9255865          DOI： 10.34067/KID.0001942022

Source DB:  PubMed          Journal:  Kidney360        ISSN： 2641-7650


× No keyword cloud information.
  8 in total

1.  Multidisciplinary team care may slow the rate of decline in renal function.

Authors:  Elizabeth A Bayliss; Bharati Bhardwaja; Colleen Ross; Arne Beck; Diane M Lanese
Journal:  Clin J Am Soc Nephrol       Date:  2011-01-27       Impact factor: 8.237

2.  Multidisciplinary breast cancer clinics. Do they work?

Authors:  M Gabel; N E Hilton; S D Nathanson
Journal:  Cancer       Date:  1997-06-15       Impact factor: 6.860

Review 3.  Diagnosis and Management of Nephrotic Syndrome in Adults.

Authors:  Charles Kodner
Journal:  Am Fam Physician       Date:  2016-03-15       Impact factor: 3.292

Review 4.  Multidisciplinary team care and outcomes in rheumatoid arthritis.

Authors:  Thea P M Vliet Vlieland
Journal:  Curr Opin Rheumatol       Date:  2004-03       Impact factor: 5.006

5.  Multidisciplinary diabetes team care: the experiences of young adults with Type 1 diabetes.

Authors:  Janice Wiley; Mary Westbrook; Janet Long; Jerry R Greenfield; Richard O Day; Jeffrey Braithwaite
Journal:  Health Expect       Date:  2013-12-18       Impact factor: 3.377

6.  All-cause costs increase exponentially with increased chronic kidney disease stage.

Authors:  Ladan Golestaneh; Paula J Alvarez; Nancy L Reaven; Susan E Funk; Karen J McGaughey; Alain Romero; Melanie S Brenner; Macaulay Onuigbo
Journal:  Am J Manag Care       Date:  2017-06       Impact factor: 2.229

7.  A Retrospective Study of Clinical and Economic Burden of Focal Segmental Glomerulosclerosis (FSGS) in the United States.

Authors:  Kamyar Kalantar-Zadeh; Christine L Baker; J Brian Copley; Daniel I Levy; Stephen Berasi; Nihad Tamimi; Jose Alvir; Suneel M Udani
Journal:  Kidney Int Rep       Date:  2021-08-09

8.  The financial and time burden associated with phenylketonuria treatment in the United States.

Authors:  Angela M Rose; Scott D Grosse; Sandra P Garcia; Janice Bach; Mary Kleyn; Norma-Jean E Simon; Lisa A Prosser
Journal:  Mol Genet Metab Rep       Date:  2019-10-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.